Aiming to find a cure for Inflammatory Bowel Diseases.


Kodosil Bio has identified an antibody directed at the IL-22 pathway that plays a key role in gastrointestinal autoimmune and inflammatory processes.



Find out more about our novel therapeutics for IBD

Learn More →


Find out more about our strategic partnerships

Learn More →